4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030297
Chief Financial Officer sold 5,940 shares at $5.04 ($29,908)
From the SEC's structured data for this filing
Trades in this filing
Koppikar Utpal · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-16 | Sale : show line 1 in the form | −5,940 | $5.04 | $29,908 | 197,589 | D |
| Open-market sales · 5,940 sh · avg $5.04 · $29,908 | ||||||
Loading xslF345X03/form4.xml…